The experimental results indicated that FDX1 silencing-induced inhibitions of cell invasion and migration were associated with inactivation of the NOD-like receptor signaling pathway (via regulation of PD-L1 expression); this provided valuable insights into the role of FDX1 in the progression of glioma. Here, FDX1 is linked to central nervous system cancer.